Equities

Faron Pharmaceuticals Oy

FARN:LSE

Faron Pharmaceuticals Oy

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)94.00
  • Today's Change-0.50 / -0.53%
  • Shares traded19.40k
  • 1 Year change-55.28%
  • Beta-0.3069
Data delayed at least 20 minutes, as of Jul 04 2024 15:48 BST.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments6.886.996.85
Total Receivables, Net0.230.911.42
Total Inventory------
Prepaid expenses1.761.843.75
Other current assets, total0.00----
Total current assets8.879.7312
Property, plant & equipment, net0.200.330.21
Goodwill, net------
Intangibles, net1.091.150.90
Long term investments--0--
Note receivable - long term0.060.060.05
Other long term assets------
Total assets101113
LIABILITIES
Accounts payable8.976.012.23
Accrued expenses1.832.042.86
Notes payable/short-term debt000
Current portion long-term debt/capital leases3.642.000.61
Other current liabilities, total0.570.421.48
Total current liabilities15107.18
Total long term debt9.47112.93
Total debt13133.55
Deferred income tax------
Minority interest------
Other liabilities, total0.901.010.15
Total liabilities252310
SHAREHOLDERS EQUITY
Common stock2.692.692.69
Additional paid-in capital------
Retained earnings (accumulated deficit)(18)(14)0.24
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.010.00(0.01)
Total equity(15)(11)2.92
Total liabilities & shareholders' equity101113
Total common shares outstanding988576
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.